Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
January 15, 2015 |

Leading 2014 M&A Transactions

The leading M&As of 2014, where the target or acquirer was based in NJ.
11 minute read
January 15, 2015 | Law.com

Leading 2014 M&A Transactions

The leading M&As of 2014, where the target or acquirer was based in NJ.
11 minute read
January 06, 2015 |

Love Him or Not, Ackman Now Runs Top Hedge Fund

William Ackman is on top of the hedge-fund world. Thanks in part to his move on Allergan, the maker of Botox, Pershing Square International posted a return of 32.8 percent for the first 10 months of 2014, making it the No. 1 fund in Bloomberg Markets' annual ranking of the best-performing large hedge funds.
4 minute read
January 06, 2015 | Law.com

Love Him or Not, Ackman Now Runs Top Hedge Fund

William Ackman is on top of the hedge-fund world. Thanks in part to his move on Allergan, the maker of Botox, Pershing Square International posted a return of 32.8 percent for the first 10 months of 2014, making it the No. 1 fund in Bloomberg Markets' annual ranking of the best-performing large hedge funds.
4 minute read
January 05, 2015 |

Big Deals

Allergan / Actavis; Halliburton / Baker Hughes; Publicis / Sapient; LabCorp / Covance; BB&T / Susquehanna; Cott / DSS Group; Chiquita / Cutrale
11 minute read
January 05, 2015 | Law.com

Big Deals

Allergan / Actavis; Halliburton / Baker Hughes; Publicis / Sapient; LabCorp / Covance; BB&T / Susquehanna; Cott / DSS Group; Chiquita / Cutrale
11 minute read
December 19, 2014 |

After Busy Year for Tech Deals, Lawyers See No Slowdown Ahead

A year that got off to a bang with the WhatsApp and Nest deals later saw a trio of spin-offs, and the climate for dealmaking remains strong heading into 2015.
6 minute read
December 03, 2014 |

Allergan Stockholders' Board-Removal Contest Was Not Ripe

Delaware courts have consistently recognized that disputes challenging corporate defensive measures are ripe for review when the defensive measures have a substantial deterrent effect on the ability of stockholders to exercise their rights.
6 minute read
November 20, 2014 |

Big Deals

Teams from Wachtell Lipton recently advised Halliburton on its $34.6 billion cash-and-stock takeover of oil field services rival Baker Hughes, and Allergan on its proposed $66 billion cash-and-stock sale to fellow pharmaceutical company Actavis.
4 minute read
November 17, 2014 |

Wachtell Rides Allergan, Halliburton to $100 Billion Deal Day

The Am Law 100's most profitable firm on a per partner basis took the lead on two big deals announced Monday: Halliburton's $34.6 billion acquisition of oil services rival Baker Hughes and Botox maker Allergan on its proposed $66 billion sale to Actavis. A half-dozen other Am Law 100 firms also had key roles on both transactions.
5 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources